The Reduced Uterine Perfusion Pressure (RUPP) rat model of preeclampsia exhibits impaired systolic function and global longitudinal strain during pregnancy.

[1]  R. Walker,et al.  Myocardial global longitudinal strain: An early indicator of cardiac interstitial fibrosis modified by spironolactone, in a unique hypertensive rat model , 2019, PloS one.

[2]  G. Pedrazzi,et al.  Maternal cardiac parameters can help in differentiating the clinical profile of preeclampsia and in predicting progression from mild to severe forms. , 2019, American journal of obstetrics and gynecology.

[3]  L. Weinert,et al.  Activin A and Late Postpartum Cardiac Dysfunction Among Women With Hypertensive Disorders of Pregnancy , 2018, Hypertension.

[4]  A. Park,et al.  Premature Cardiac Disease and Death in Women Whose Infant Was Preterm and Small for Gestational Age: A Retrospective Cohort Study , 2018, JAMA cardiology.

[5]  A. Tung,et al.  Abnormal mid-trimester cardiac strain in women with chronic hypertension predates superimposed preeclampsia. , 2017, Pregnancy hypertension.

[6]  A. Franx,et al.  Exposure to placental ischemia impairs postpartum maternal renal and cardiac function in rats. , 2017, American journal of physiology. Regulatory, integrative and comparative physiology.

[7]  D. Talmor,et al.  Circulating Antiangiogenic Factors and Myocardial Dysfunction in Hypertensive Disorders of Pregnancy , 2016, Hypertension.

[8]  T. Edvardsen,et al.  Strain echocardiography is related to fibrosis and ventricular arrhythmias in hypertrophic cardiomyopathy , 2016, European heart journal cardiovascular Imaging.

[9]  Xiaoqian Yang,et al.  Maternal cardiac remodeling and dysfunction in preeclampsia: a three-dimensional speckle-tracking echocardiography study , 2015, The International Journal of Cardiovascular Imaging.

[10]  B. Thilaganathan,et al.  Cardiovascular Implications in Preeclampsia: An Overview , 2014, Circulation.

[11]  C. Ananth,et al.  Pre-eclampsia rates in the United States, 1980-2010: age-period-cohort analysis , 2013, BMJ.

[12]  P. Leeson,et al.  Cardiac dysfunction and preeclampsia: can imaging give clues to mechanism? , 2012, Circulation. Cardiovascular imaging.

[13]  M. Eghbali,et al.  Cardiac structural and hemodynamic changes associated with physiological heart hypertrophy of pregnancy are reversed postpartum. , 2012, Journal of applied physiology.

[14]  G. Gulati,et al.  Subclinical Left Ventricular Dysfunction in Preeclamptic Women With Preserved Left Ventricular Ejection Fraction: A 2D Speckle-Tracking Imaging Study , 2012, Circulation. Cardiovascular imaging.

[15]  J. Granger,et al.  Linking placental ischemia and hypertension in preeclampsia: role of endothelin 1. , 2012, Hypertension.

[16]  B. LaMarca,et al.  A model of preeclampsia in rats: the reduced uterine perfusion pressure (RUPP) model. , 2012, American journal of physiology. Heart and circulatory physiology.

[17]  John Mitchell,et al.  Cardiac Angiogenic Imbalance Leads to Peri-partum Cardiomyopathy , 2012, Nature.

[18]  B. Thilaganathan,et al.  Maternal cardiac function in preeclampsia , 2011, Current opinion in obstetrics & gynecology.

[19]  G. Sutherland,et al.  Preeclampsia Is Associated With Persistent Postpartum Cardiovascular Impairment , 2011, Hypertension.

[20]  K. Joseph,et al.  Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy. , 2011, Best practice & research. Clinical obstetrics & gynaecology.

[21]  R. Asmar,et al.  Pre-eclampsia: pathophysiology, diagnosis, and management , 2011, Vascular health and risk management.

[22]  J. Granger,et al.  Changes in cardiac structure in hypertension produced by placental ischemia in pregnant rats: effect of tumor necrosis factor blockade , 2011, Journal of hypertension.

[23]  G. Sutherland,et al.  Maternal Cardiac Dysfunction and Remodeling in Women With Preeclampsia at Term , 2011, Hypertension.

[24]  J. Granger,et al.  Hypertension in Response to Chronic Reductions in Uterine Perfusion in Pregnant Rats: Effect of Tumor Necrosis Factor-&agr; Blockade , 2008, Hypertension.

[25]  J. Granger,et al.  Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction. , 2008, American journal of physiology. Heart and circulatory physiology.

[26]  J. Granger,et al.  Inflammatory cytokines in the pathophysiology of hypertension during preeclampsia , 2007, Current hypertension reports.

[27]  A. Hingorani,et al.  Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis , 2007, BMJ : British Medical Journal.

[28]  J. Granger,et al.  Effects of reduced uterine perfusion pressure on blood pressure and metabolic factors in the pregnant rat , 2007, American journal of hypertension.

[29]  J. Granger,et al.  Hypertension Produced by Reductions in Uterine Perfusion in the Pregnant Rat: Role of Tumor Necrosis Factor-&agr; , 2005, Hypertension.

[30]  G. Dekker,et al.  Pre-eclampsia , 2005, The Lancet.

[31]  L. Duley.  Pre-eclampsia and the hypertensive disorders of pregnancy. , 2003, British medical bulletin.

[32]  J. Granger,et al.  Pathophysiology of hypertension during preeclampsia linking placental ischemia with endothelial dysfunction. , 2001, Hypertension.

[33]  J. Pell,et al.  Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129 290 births , 2001, The Lancet.

[34]  J. Morrison,et al.  Cardiac troponin I in pre‐eclampsia and gestational hypertension , 2000, BJOG : an international journal of obstetrics and gynaecology.

[35]  James J. Walker,et al.  Pre-eclampsia , 2000, The Lancet.

[36]  S. Sengupta,et al.  Gestational changes in left ventricular myocardial contractile function: new insights from two-dimensional speckle tracking echocardiography , 2016, The International Journal of Cardiovascular Imaging.

[37]  J. Granger,et al.  International Journal of Molecular Sciences the Endothelin Type a Receptor as a Potential Therapeutic Target in Preeclampsia , 2022 .